Assessing the validity of abbreviated literature searches for rapid reviews: protocol of a non-inferiority and meta-epidemiologic study by Barbara Nussbaumer-Streit et al.
PROTOCOL Open Access
Assessing the validity of abbreviated
literature searches for rapid reviews:
protocol of a non-inferiority and meta-
epidemiologic study
Barbara Nussbaumer-Streit1*, Irma Klerings2, Gernot Wagner2, Viktoria Titscher2 and Gerald Gartlehner1,3
Abstract
Background: Systematic reviews offer the most reliable and valid support for health policy decision-making, patient
information, and guideline development. However, they are labor intensive and frequently take longer than 1 year
to complete. Consequently, they often do not meet the needs of those who need to make decisions quickly. Rapid
reviews have therefore become a pragmatic alternative to systematic reviews. They are knowledge syntheses that
abbreviate certain methodological aspects of systematic reviews to produce information more quickly. Methodological
shortcuts often take place in literature identification. A potential drawback is less reliable results. To date, the impact of
abbreviated searches on estimates of treatment effects and subsequent conclusions has not been analyzed systematically
across multiple bodies of evidence. We aim to answer the research question: Do bodies of evidence that are based on
abbreviated literature searches lead to different conclusions about benefits and harms of interventions compared with
bodies of evidence that are based on comprehensive, systematic literature searches?
Methods: We will use a non-inferiority and meta-epidemiologic design. The primary outcome is the proportion of
discordant conclusions based on different search approaches. Drawing of a pool of Cochrane reports published between
2012 and 2016, we will randomly select 60 reports. Eligible reports are those that present a summary-of-findings table,
draw a clear conclusion, present data for meta-analyses, and document the search strategy clearly. We will conduct
several abbreviated searches to detect whether included studies in these Cochrane reviews could be detected. If searches
could not detect all studies, we will revise the original summary-of-findings table and ask review authors whether the
missed evidence would change conclusions of their report. We will determine the proportion of discordant conclusions
for each abbreviated search approach. We will consider an abbreviated search as non-inferior if the lower limit of the 95%
confidence interval of the proportion of discordant conclusions is below the non-inferiority margin, which is determined
based on results of a survey for clinical and public health scenarios.
Discussion: This will be the first study to assess whether the reduced sensitivity of abbreviated searches has an impact
on conclusions across multiple bodies of evidence, not only on effect estimates.
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Background
Because of their high methodological standards in sum-
marizing primary research, systematic reviews offer the
most reliable and valid support for clinical and health
policy decision-making, patient information, and guide-
line development. They aim to ensure methodological
rigor. Systematic reviews are time- and labor-intense
and thus are expensive. Because systematic reviews can
take up to 24 months to complete [1, 2], they often do
not meet the time-sensitive needs of decision-makers.
Consequently, rapid reviews have become a pragmatic
alternative to systematic reviews. Rapid reviews are
knowledge syntheses that simplify certain methodo-
logical aspects of systematic reviews. By doing so, they
make results available in a shorter timeframe ranging
from a few weeks to a few months [3]. The methodo-
logical underpinnings of rapid reviews are heterogeneous
and employ diverse approaches with a strong focus on
the specific needs of decision-makers [2, 4]. Although no
universally accepted definition of rapid reviews exists,
most methodological shortcuts when conducting a rapid
review take place in those areas which are most time-
consuming, in particular literature identification, quality
assessment, and evidence synthesis [5]. A potential
trade-off of rapid reviews is that their results can have a
lower level of reliability than the results of systematic
reviews. Studies comparing findings of rapid reviews
with those of systematic reviews provide mixed results
regarding concordance of conclusions [6–8].
A frequently employed approach in rapid reviews is to
streamline literature searches [9]. Rapid review investiga-
tors often omit time-consuming search strategies such
as searches in multiple electronic databases, hand-
searches, searches for gray literature, or citation tracking.
Several methodological studies have shown that abbrevi-
ated search strategies do not detect the same amount of
relevant studies that comprehensive systematic searches
do [10–14]. The extra effort to find the totality of pub-
lished studies, however, is often high. In a study on
public health interventions for the prevention of cardio-
vascular disease, researchers found 31 of 34 studies with
a search in MEDLINE only. Investigators had to search
three additional electronic databases to detect the
remaining three studies [13]. Likewise, in another recent
study of streamlined searches using chronic depression
as an example, investigators were able to identify 42 out
of 50 studies by sensitive searches of electronic data-
bases [15]. The remaining eight studies could only be
found by supplementary search strategies such as
citation tracking, screening reference lists, searching
clinical trial registers, and contacting authors of included
studies. The investigators concluded, however, that
the studies missed by electronic database searches
would not have had a significant impact on overall
meta-analyses results and would not have affected
conclusions. Furthermore, these studies were charac-
terized by higher risks of bias. Likewise, Halladay
et al. found that searches beyond PubMed for thera-
peutic interventions have little impact on meta-
analyses results [14]. By contrast, a methods study
with a focus on observational studies suggests that
searches in single databases for observational studies
do not provide comprehensive summaries of the
existing literature [16].
The studies described above focused on single topics
or changes in point estimates of meta-analyses. To date,
the question whether the reduced sensitivity of abbrevi-
ated searches has an impact on estimates of treatment
effects (beneficial and harmful) and subsequent conclu-
sions has not been analyzed systematically across
multiple bodies of evidence.
Methods
Aim and research question
The aim of the study is to assess the impact of various
streamlined searches on conclusions about benefits and
harms of an intervention. We will focus on two areas of
interest: (1) clinical topics for which randomized con-
trolled trials tend to provide the most reliable evidence
and (2) public health topics for which randomized
controlled trials are often not available and evidence
comes from observational studies.
With our study we want to answer the following
research question.
Do bodies of evidence that are based on abbreviated
literature searches lead to different conclusions about
benefits and harms of interventions compared with
bodies of evidence that are based on comprehensive,
systematic literature searches?
Study design
The study will use a non-inferiority and meta-
epidemiologic design to test whether different abbrevi-
ated searches are non-inferior to (i.e., not worse than)
comprehensive, systematic literature searches. The pri-
mary outcome of interest is the proportion of discordant
conclusions based on different search approaches for the
same key questions. Conclusions based on comprehen-
sive systematic literature searches will serve as the refer-
ence standard. We denote the conclusions based on
comprehensive systematic literature searches as CS and
those based on various abbreviated searches as CA(1−k).
The proportion of discordant conclusions based on the
two search approaches would then be:
θ ¼ CS ‐CA 1‐kð Þ
 
=n;
where n is the number of conclusions.
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The non-inferiority margin (ε) in our study reflects the
maximum risk of getting an incorrect answer from a
rapid review that decision-makers are willing to accept
in exchange for getting the product rapidly. We define
an incorrect answer as a result that is different enough
in direction or magnitude of effect compared with a
result from a systematic review that the difference would
trigger a signal to update a systematic review based on a
modified approach by Shojania et al. [17] (Table 1).
Incorrect answers of rapid reviews might lead to false
conclusions. For the purpose of our study, we define
false conclusion as a conclusion that is different from a
conclusion based on a body of evidence derived from a
comprehensive systematic literature search.
The null hypothesis of our study is denoted as θ > ε
(abbreviated searches are inferior), whereas the alterna-
tive hypothesis can be denoted as θ ≤ ε (abbreviated
searches are non-inferior).
We will consider an abbreviated search as non-inferior
if the lower limit of the 95% confidence interval of the
proportion of discordant conclusions is below the non-
inferiority margin of 0.1. With a non-inferiority margin
of 0.1 (i.e., decision-makers are willing to accept an in-
correct answer in one out of ten decisions based on a
rapid review), we would conclude that abbreviated
searches are non-inferior if the lower confidence interval
of discordant conclusions does not cross this threshold.
Figure 1 depicts two possible scenarios. In scenario 1,
the lower limit of the confidence interval does not cross
the non-inferiority margin, demonstrating non-inferiority
of abbreviated searches relative to the gold standard of
systematic searches. In scenario 2, the lower confidence
limit crosses the non-inferiority margin. We would
conclude that abbreviated searches are inferior.
Determination of non-inferiority margin
We recently conducted an international, online survey
with stakeholders and decision-makers in the health care
sector. The aim of the study was to determine the max-
imum risk of getting an incorrect (wrong or inaccurate)
answer from a rapid review that decision-makers are
willing to accept in exchange for a rapid evidence syn-
thesis. The survey targeted guideline developers and
decision-makers who work in regulatory agencies, health
insurance companies, or health policy agencies and have
experience using evidence summaries. Survey language
was English, German, and Spanish. The survey has now
closed and 334 persons from 33 countries have partici-
pated. Preliminary results show that, on average, respon-
dents are willing to accept a maximum risk of getting an
incorrect answer of 10% (median).
We determined the non-inferiority thresholds based on
results of this survey for clinical and public health scenarios.
Determining sample size
Based on the non-inferiority margin, we conducted
sample-size calculations for the number of Cochrane
reviews needed using Simon’s two-stage design [18].
Table 2 presents required sample sizes of Cochrane
reviews for different non-inferiority margins for corre-
lated marginal proportions. All calculations are based on
a significance level of 0.025 and a power of 0.9. Based on
the 10% non-inferiority margin, we require a minimum
of 60 Cochrane reviews.
Eligible evidence base
We will choose Cochrane reports that fulfill the follow-
ing inclusion criteria:
1. Authors were able to draw a conclusion about the
effectiveness or risk of harms of a treatment compared
with a control intervention.We will exclude Cochrane
reports that state that the evidence is insufficient to
determine efficacy, effectiveness, or risk of harms.
2. Relevant outcomes are presented in a summary-of-
findings table including grades of the quality of
evidence for each outcome according to the GRADE
(Grading of Recommendations Assessment,
Development and Evaluation) approach.
3. Data for meta-analyses are clearly presented to be able
to reproduce the analyses.We will also include
Cochrane reports that couldn’t calculate a meta-analysis,
because only one study was identified, if the authors
were able to draw a conclusion based on this study.
4. Searches are reported in enough detail to replicate
the search strategy in selected databases.
5. The most recent literature search was run in 2012 or
later, and the date of the searches (at least months
and year) is reported.
6. The review focuses on one of the following clinical
topics or on a public health topic:
 Cardiovascular disease (e.g., myocardial infarction)
 Cerebrovascular disease (e.g., stroke)
 Osteoarthritis
 Chronic respiratory conditions (e.g., chronic
obstructive pulmonary disease)
 Mental health
Table 1 Criteria for an “incorrect answer” based on difference in
statistical significance and magnitude of effect
Criteria for incorrect answer
Change in statistical
significance
Statistical significance changes between graded
effect and gold standard effect (trivial changes in
p values within the range of 0.04 to 0.06 are not
considered as a change).
Change in magnitude
of effect
Difference in magnitude of effects is larger than
a relative risk change (increase or reduction) of
25 percentage points for dichotomous outcomes
or 0.20 SMDs for continuous outcomes.
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We narrowed the scope of clinical topics to disease
categories that appear on numerous authoritative lists of
“priority conditions” from e.g., the Institute of Medicine,
the Centers for Disease Control and Prevention, or the
Agency for Healthcare Research and Quality. We will
not narrow the scope of public health topics, because
only a limited number of public health Cochrane reviews
have been published.
Identifying the evidence base
We will systematically search the Cochrane Library from
2012 to 2016 to find Cochrane reports that present the
quality of evidence in summary-of-findings tables. We
chose 2012 as start date because with using CRS Online
interface it is only possible to identify when a record was
added to CENTRAL for records added after 2011.
According to the Methodological Expectations of Cochrane
Intervention Reviews (MECIR), summary-of-findings tables
are highly desirable but not mandatory [19]. Consequently,
not all Cochrane reviews present them. We will use “quality
of evidence” OR “summary of findings” as search terms.
Out of the pool of unsorted Cochrane reports with
summary-of-findings tables, we will assign a random num-
ber to each Cochrane review that was identified by our
searches. We will then rank the reviews by random number
and apply our eligibility criteria sequentially to each review
until we have at least 60 reviews. Ranking the reviews by
random numbers helps us to avoid bias due to publication
date, because it makes the order of reports that we screen
for eligibility random. For the identification of eligible
Cochrane reports, we will use a pilot-tested review form.
Because the change in conclusions is the primary
outcome of interest, we will focus on all outcomes
(dichotomous and continuous) presented in the main
summary-of-findings table. Outcomes presented in the
summary-of-findings tables are usually those that
reviewers viewed as most important for decision-making.
Data collection
For each eligible review, we will extract bibliographic
information about included studies. We will extract gen-
eral information about the publication (authors, journal,
publication year, etc.) and database-specific identification
numbers. We will then check whether the included pub-
lications (if more than one publication is available for a
given study, we will search for each publication that is
included in the Cochrane report) could have been
detected at the date of the search of the respective
Cochrane report with only the following sources searched:
Fig. 1 Two different possible results of a non-inferiority study comparing abbreviated searches with systematic searches
Table 2 Exemplary sample size calculations for different non-
inferiority margins
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 PubMed or MEDLINE only
 CENTRAL (Cochrane Central Register of Controlled
Trials) only
 Embase only
 PubMed or MEDLINE plus CENTRAL
 PubMed or MEDLINE plus Embase
 CENTRAL plus Embase
 PubMed or MEDLINE plus CENTRAL plus Embase
 PubMed or MEDLINE plus reference lists
 CENTRAL plus reference lists
 Embase plus reference lists
 PubMed or MEDLINE plus CENTRAL plus
reference lists
 CENTRAL plus Embase plus reference lists
 PubMed or MEDLINE plus CENTRAL plus Embase
plus reference lists
 PubMed or MEDLINE plus Embase plus reference lists
The database choice is based on the Methodological
Expectations of Cochrane Intervention Reviews (MECIR)
which demand that MEDLINE, Embase, and CENTRAL
are searched [19]. We chose these combinations of data-
bases and reference tracking because a study exploring
methods of rapid reviews reported that the majority of stud-
ies looking at abbreviated searches only searched one data-
base with or without additional handsearches of reference
lists of included studies [4]. Thus, it is unknown whether
the abbreviated searches could affect conclusions of reviews.
To identify publications in the respective databases,
we will either use database-specific identification num-
bers (PubMed ID (PMID), Central ID, Embase Accession
Number) if available, or search strings combining author
names, title words, and additional bibliographic informa-
tion (journal of publication, year, volume, etc.). We will
also limit the search results by entry date to determine
whether the record was available at the time of the
original search (as defined by the date of the last search
documented in the review).
In a second step, we will rerun the original MEDLINE,
CENTRAL, and Embase searches documented in the
review. We will then test if the references present in the
databases were identified by the search strategy. This
step is important because recall, defined as the number
of studies that are actually identified through search
strategies, is usually below the total possible coverage.
One study suggests that e.g., in Medline only about three
quarters of listed studies could actually be identified by
search strategies [20]. Or, if available, we will use the
archived search results provided by Cochrane infor-
mation specialists, who conducted the search for the
Cochrane review. We will do formal quality assess-
ment of search strategies: spelling, syntax and opera-
tors of searches will be checked and minor errors will
be corrected.
Reference lists of included studies found in each data-
base will be exported from Scopus. To identify Scopus
records, we will use PMID if available, or search strings
combining author names, title words and additional bib-
liographic information (journal of publication, year,
volume, etc.).
We will determine the proportion of studies included
in the Cochrane reviews that were detected with each
abbreviated search approach.
Data analysis
To determine whether approaches are non-inferior to
comprehensive systematic searches, we will employ
qualitative and quantitative methods. We will assess
concordance of conclusions as well as concordance of
effect estimates. We will contact the Cochrane Central
Editorial team to provide us with the original RevMan
files for each selected Cochrane report. RevMan is
the software Cochrane authors use to write and edit
their reviews.
Assessing concordance of conclusions
We will compare effect estimates in Cochrane reviews
with those from studies identified in abbreviated litera-
ture searches. We will conduct meta-analyses with the
eligible studies detected by each abbreviated search
approach using the same statistical approach as the
respective Cochrane report. For each abbreviated search,
team members experienced with GRADE will revise the
summary-of-findings table from the underlying Cochrane
report and update number of studies, and effect estimates,
but not the grading of the quality of evidence. We will
highlight differences between original summary of find-
ings tables and those based on abbreviated searches in
comparison tables.
We will contact review authors of the underlying
Cochrane reviews and ask them for a judgment whether
the missed evidence would change conclusions of their
report. We would like them to decide whether the
evidence base from abbreviated searches changes their
conclusion, to keep it consistent and avoid bias due to
different judge. We will supply them with the revised
summary of findings tables and the comparison tables.
Review authors will have the choice between two
answers:
1) The body of evidence based on an abbreviated search
would lead to the same conclusion (concordant
conclusion).
2) The body of evidence based on an abbreviated search
would lead to a different conclusion (discordant
conclusion).
If authors opt to change their conclusions, we will
ask them to indicate whether:
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a) They have made the conclusion less definitive,
but maintained the direction (positive or negative)
of the original conclusion (e.g., by adding adverbs
of probability such as “maybe,” “might,” etc.).
b) They could no longer draw a conclusion.
c) They have changed the direction of the
conclusion (made a positive conclusion negative
or a negative one positive) but also included an
adverb to make the conclusion less definitive (e.g.,
from “is effective or might be effective” to “might
not be effective”).
d) They have changed the direction of the
conclusion (made a positive conclusion negative
or a negative one positive), and state the newly
derived conclusion in absolute terms (e.g., from “is
effective or might be effective” to “is not effective”).
We will pilot our approach to ensure high response
rates and valid responses.
As outlined above (see Fig. 1), we will then determine
the proportion of discordant conclusions for each abbre-
viated search approach for clinical and public health
conditions and assess whether the lower limit of the
confidence interval crosses the non-inferiority margin.
Assessing concordance of effect estimates
To assess concordance of effect estimates, we will com-
pare effect estimates in Cochrane reviews with those
from studies identified in abbreviated literature searches.
For this analysis, we will focus on one primary outcome
for efficacy and harm of each included Cochrane report.
In case, there are more eligible outcomes in one report,
we will use the primary outcome based on most studies.
We will only include dichotomous outcomes. We do not
include continuous outcomes for this analysis because
thresholds for clinical relevance are often difficult to
determine. They would, for example, require information
on minimal important differences, which is not available
for many scales. To obtain the same direction of effects
across all meta-analyses, we will recalculate effect esti-
mates, if necessary, so that all results will be expressed
as odds ratios of desirable results (e.g., response to treat-
ment instead of failure to respond, survival instead of
mortality). An odds ratio of less than 1.0 will represent
undesirable effects, an odds ratio of larger than 1.0 will
represent desirable treatment effects.
We will compare differences in effect estimates
between the Cochrane reports and the evidence detected
by streamlined search approaches using ratios of odds
ratios and random effects models. To achieve an overall
estimate of the difference, we will pool the ratios of odds
ratios. Overall, we will follow a method outlined by
Sterne et al about meta-epidemiological research [21]. In
addition, we will determine the percentage weight con-
tributed by studies that abbreviated searches did not
detect to individual meta-analyses in the Cochrane
reports.
Discussion
To the best of our knowledge, this will be the first study
to assess whether the reduced sensitivity of abbreviated
searches has an impact on conclusions across multiple
bodies of evidence, not only on effect estimates. The
strengths of our study are
– that we involve review authors and ask them to
reassess their original conclusions based on a new
evidence base generated by abbreviated searches,
– that we quantify the non-inferiority of abbreviated
searches by employing a non-inferiority margin
assessed by a survey of health policy decision-makers
and guideline developers.
The project does not aim to abolish full systematic
reviews but to provide a rationale for or against the use
of rapid reviews where these are the only seemingly
feasible way to support decision-making.
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